Search Results | Clinical Cancer Research | American Association for Cancer Research

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Tumor-Derived GM-CSF Promotes Granulocyte Immunosuppression in Mesothelioma Patients

Swati Khanna, Suzanne Graef, Francis Mussai, Anish Thomas, Neha Wali, Bahar Guliz Yenidunya, Constance Yuan, Betsy Morrow, Jingli Zhang, Firouzeh Korangy, Tim F. Greten, Seth M. Steinberg, Maryalice Stetler-Stevenson, Gary Middleton, Carmela De Santo, Raffit Hassan

Clin Cancer Res (2018) 24 (12): 2859–2872.

DOI: https://doi.org/10.1158/1078-0432.CCR-17-3757

Published: 14 June 2018

View article

Includes: Supplementary data

Journal Articles

Efficacy of Anti-mesothelin Immunotoxin RG7787 plus Nab-Paclitaxel against Mesothelioma Patient–Derived Xenografts and Mesothelin as a Biomarker of Tumor Response

Jingli Zhang, Swati Khanna, Qun Jiang, Christine Alewine, Markku Miettinen, Ira Pastan, Raffit Hassan

Clin Cancer Res (2017) 23 (6): 1564–1574.

DOI: https://doi.org/10.1158/1078-0432.CCR-16-1667

Published: 14 March 2017

View article

Includes: Supplementary data

Journal Articles

Anti–Mesothelin Immunotoxin SS1P in Combination with Gemcitabine Results in Increased Activity against Mesothelin-Expressing Tumor Xenografts

Raffit Hassan, V. Courtney Broaddus, Shannon Wilson, David J. Liewehr, Jingli Zhang

Clin Cancer Res (2007) 13 (23): 7166–7171.

DOI: https://doi.org/10.1158/1078-0432.CCR-07-1592

Published: 03 December 2007

View article

Journal Articles

Detection and Quantitation of Serum Mesothelin, a Tumor Marker for Patients with Mesothelioma and Ovarian Cancer

Raffit Hassan, Alan T. Remaley, Maureen L. Sampson, Jingli Zhang, Derrick D. Cox, James Pingpank, Richard Alexander, Mark Willingham, Ira Pastan, Masanori Onda

Clin Cancer Res (2006) 12 (2): 447–453.

DOI: https://doi.org/10.1158/1078-0432.CCR-05-1477

Published: 20 January 2006

View article

Journal Articles

Humoral Immune Response to Mesothelin in Mesothelioma and Ovarian Cancer Patients

Mitchell Ho, Raffit Hassan, Jingli Zhang, Qing-cheng Wang, Masanori Onda, Tapan Bera, Ira Pastan

Clin Cancer Res (2005) 11 (10): 3814–3820.

DOI: https://doi.org/10.1158/1078-0432.CCR-04-2304

Published: 16 May 2005

View article

NARROW

Tumor-Derived GM-CSF Promotes Granulocyte Immunosuppression in Mesothelioma Patients

Efficacy of Anti-mesothelin Immunotoxin RG7787 plus Nab-Paclitaxel against Mesothelioma Patient–Derived Xenografts and Mesothelin as a Biomarker of Tumor Response

Anti–Mesothelin Immunotoxin SS1P in Combination with Gemcitabine Results in Increased Activity against Mesothelin-Expressing Tumor Xenografts

Detection and Quantitation of Serum Mesothelin, a Tumor Marker for Patients with Mesothelioma and Ovarian Cancer

Humoral Immune Response to Mesothelin in Mesothelioma and Ovarian Cancer Patients

Email alerts

AACR Journals

Tumor-Derived GM-CSF Promotes Granulocyte Immunosuppression in Mesothelioma Patients

Efficacy of Anti-mesothelin Immunotoxin RG7787 plus Nab-Paclitaxel against Mesothelioma Patient–Derived Xenografts and Mesothelin as a Biomarker of Tumor Response

Anti–Mesothelin Immunotoxin SS1P in Combination with Gemcitabine Results in Increased Activity against Mesothelin-Expressing Tumor Xenografts

Detection and Quantitation of Serum Mesothelin, a Tumor Marker for Patients with Mesothelioma and Ovarian Cancer

Humoral Immune Response to Mesothelin in Mesothelioma and Ovarian Cancer Patients

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only